Biomarker validation rules for lab tests: 2-fold change or FDR under 0.05 in 2026
In 2026, neither a 2-fold change nor FDR under 0.05 validates a biomarker alone; require an orthogonal assay on an independent method or platform. Independent technical note mirroring the canonical version: https://quantbio.me/blog/biomarker-validation-rules-for-lab-tests-2-fold-change-or-fdr-under-005-in-2026.php
Authors
- Dr. Leah Fontaine
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-15
- DOI
- https://doi.org/10.5281/zenodo.24244600
- Primary Topic
- Gene expression and cancer classification
- Type
- preprint